Page last updated: 2024-10-25

clonazepam and Cochlear Hearing Loss

clonazepam has been researched along with Cochlear Hearing Loss in 2 studies

Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gowdar, G1
Nyamagoudar, A1
Chezhian I, P1
Kreisel, SH1
Binder, J1
Wöhrle, JC1
Krauss, JK1
Hofmann, S1
Bauer, MF1
Hennerici, MG1
Bäzner, H1

Other Studies

2 other studies available for clonazepam and Cochlear Hearing Loss

ArticleYear
Schimmelpenning feuerstein-mims syndrome with isolated enlargement of left temporal lobe.
    Indian journal of pediatrics, 2015, Volume: 82, Issue:2

    Topics: Anticonvulsants; Clonazepam; Diagnosis, Differential; Electroencephalography; Hearing Loss, Sensorin

2015
Dystonia in the Mohr-Tranebjaerg syndrome responds to GABAergic substances.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:10

    Topics: Adult; Clonazepam; Cognition Disorders; Dystonic Disorders; GABA Modulators; Genetic Diseases, X-Lin

2004